Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/186609
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHoijman Kleinman, Esteban-
dc.contributor.authorRocha Viegas, Luciana-
dc.contributor.authorKeller Sarmiento, María Inés-
dc.contributor.authorRosenstein, Ruth E.-
dc.contributor.authorPecci, Adali-
dc.date.accessioned2022-06-14T15:50:50Z-
dc.date.available2022-06-14T15:50:50Z-
dc.date.issued2004-01-
dc.identifier.issn0013-7227-
dc.identifier.urihttp://hdl.handle.net/2445/186609-
dc.description.abstractThe antiapoptotic effect of melatonin has been described in several systems. In this study, the antagonistic effect of the methoxyindole on dexamethasone-induced apoptosis in mouse thymocytes was examined. Melatonin decreased both DNA fragmentation, and the number of annexin V-positive cells incubated in the presence of dexamethasone. Analysis of the expression of the members of the Bcl-2 family indicated that the synthetic glucocorticoid increased Bax protein levels without affecting the levels of Bcl-2, Bcl-XL, Bcl-XS, or Bak. This effect correlated with an increase in thymocytes bax mRNA levels. Dexamethasone also increased the release of cytochrome C from mitochondria. All of these effects were reduced in the presence of melatonin, which was ineffective per se on these parameters. In addition, the involvement of cAMP on glucocorticoid/melatonin antagonism was examined. Both melatonin and dexamethasone decreased the levels of this nucleotide in mouse thymocytes, indicating that the antagonistic action between both hormones involves a cAMP-independent pathway. In summary, the present results suggest that the antiapoptotic effect of melatonin on glucocorticoid-treated thymocytes would be a consequence of an inhibition of the mitochondrial pathway, presumably through the regulation of Bax protein levels.-
dc.format.extent8 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherAssociation for the Study of Internal Secretions-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1210/en.2003-0764-
dc.relation.ispartofEndocrinology, 2004, vol. 145, num. 1, p. 418-425-
dc.relation.urihttps://doi.org/10.1210/en.2003-0764-
dc.rights(c) Association for the Study of Internal Secretions, 2004-
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)-
dc.subject.classificationApoptosi-
dc.subject.classificationMelatonina-
dc.subject.classificationGlucocorticoides-
dc.subject.classificationProteïnes-
dc.subject.otherApoptosis-
dc.subject.otherMelatonin-
dc.subject.otherGlucocorticoids-
dc.subject.otherProteins-
dc.titleInvolvement of Bax protein in the prevention of glucocorticoid-induced thymocytes apoptosis by melatonin-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec715246-
dc.date.updated2022-06-14T15:50:51Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid14500572-
Appears in Collections:Articles publicats en revistes (Patologia i Terapèutica Experimental)

Files in This Item:
File Description SizeFormat 
715246.pdf1 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.